3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Withdrawn
1
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Interventions
Cisplatin
32
Paclitaxel
29
Radiotherapy
21
Fluorouracil
20
Radiation
12
camrelizumab
11
Oxaliplatin
11
Docetaxel
11
Carboplatin
10
Capecitabine
9
Esophagectomy
8
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
6
Leucovorin
6
Endoscopic Mucosal Resection
6
Drug Therapy
6
apatinib
5
Neoadjuvant Therapy
5
Chemoradiotherapy
5
nedaplatin
4
S 1 (combination)
4
Preoperative Exercise
4
Irinotecan
4
Endoscopy
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
pembrolizumab
3
TP protocol
3
Radiotherapy, Adjuvant
3
Epirubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Esophageal Neoplasms
×
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
×
Clear all
NCT03757754
2018-11-29
HPPH
Zhejiang Hisun Pharmaceutical Co. Ltd.
Phase 1
Unknown
30 enrolled